Greg W. Kilby
Geen lopende functies
Profiel
Greg W.
Kilby worked as the Chief Bioanalytics Officer at Protea Biosciences, Inc. and Protea Biosciences Group, Inc. from 2014 to 2016.
He holds a doctorate degree from the University of Wollongong, which was conferred in 1996.
Eerdere bekende functies van Greg W. Kilby
| Bedrijven | Functie | Einde |
|---|---|---|
| PROTEA BIOSCIENCES GROUP, INC | Corporate Officer/Principal | 15-09-2016 |
Protea Biosciences, Inc.
 Protea Biosciences, Inc. Medical SpecialtiesHealth Technology Protea Biosciences, Inc. develops technology for micro fluidic protein separation and detection. The firm develops new technology for the identification, characterization, and quantization of biologically-important molecules for basic research, pharmaceutical development, and diagnostic applications. the company was founded by Steve Turner in 2001 and is headquartered in Morgantown, WV. | Corporate Officer/Principal | - |
Opleiding van Greg W. Kilby
| University of Wollongong | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Protea Biosciences Group, Inc.
 Protea Biosciences Group, Inc. Miscellaneous Commercial ServicesCommercial Services Protea Biosciences Group, Inc. engaged in the provision of molecular information services. It offers direct analysis, mapping, and display of biologically active molecules in living cells and tissue samples through its platform technology. The company was founded by Stephen C. Turner in July 2001 and was headquartered in Morgantown, WV. | Commercial Services |
Protea Biosciences, Inc.
Protea Biosciences, Inc. Medical SpecialtiesHealth Technology Protea Biosciences, Inc. develops technology for micro fluidic protein separation and detection. The firm develops new technology for the identification, characterization, and quantization of biologically-important molecules for basic research, pharmaceutical development, and diagnostic applications. the company was founded by Steve Turner in 2001 and is headquartered in Morgantown, WV. | Health Technology |
